Search Results
Results found for "Edward Stites"
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
In states such as Michigan and Pennsylvania, it has been detected in more than one in four fentanyl-related
- 📰 GPCR Weekly News, August 14 to 20, 2023
and Molecular Insights into GPCR Function A method for structure determination of GPCRs in various states
- 📰 GPCR Weekly News, March 6 to 12, 2023
Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery.
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
presynaptic integration.SIGNIFICANCE STATEMENTTwo G protein coupled receptors colocalize at presynaptic sites
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
The Kinetic Edge You Can’t Afford to Ignore Steady state isn’t just about exposure anymore.
- 📰 GPCR Weekly News, March 4 to 10, 2024
Activation Molecular dynamics-based identification of binding pathways and two distinct high-affinity sites
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Slopes <1 may reveal allosteric modulation , where the antagonist binds at a secondary site.
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Model patient-like pathophysiological states (e.g., reduced receptor expression in heart failure).
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Research Fluorescent Ligands Enable Target Engagement Studies for the Intracellular Allosteric Binding Site
- 📰 GPCR Weekly News, February 5 to 11, 2024
Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State
- VAMP2: a crucial player in the delivery of MOR to the synapse
Phosphorylation state of muopioid receptor determines the alternative recycling of receptor via Rab4
- 📰 GPCR Weekly News, June 24 to 30, 2024
intracellular loop 3 in β2-adrenergic receptor Extensive location bias of the GPCR-dependent translatome via site-selective
- 📰 GPCR Weekly News, September 18 to 24, 2023
Form 483 findings at Novo Nordisk's North Carolina semaglutide plant Excellerate Bioscience Announces Site
- GPCR Collaboration: From Models to Medicine
Biased signaling, allosteric binding sites, and subtype selectivity mean there is rarely a straight line
- From Snapshots to Predictions: Why Mechanism of Action Matters
The shift plateaus once the allosteric site saturates.
- Chemokine receptor-targeted drug discovery: progress and challenges
Therefore, the in vivo state of the receptor and its existence as homo and herero-oligomeres at the cell
- 📰 GPCR Weekly News, January 15 to 21, 2024
The course covers basic pharmacology in four weekly segments and is open to all with a free site membership
- 📰 GPCR Weekly News, May 29 to June 4, 2023
An Atomic Level Investigation of Sodium Ions Regulating Agonist and Antagonist Binding in the Active Site
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
: Congrats to: Our contributor, Cam Sinh Lu , who has just released an incredible article on our site
- New role of β-arrestins in MOR signaling
marked the beginning of its study with the first discoveries which suggested that there were "binding sites
- 📰 GPCR Weekly News, May 6 to 12, 2024
mimetic-dependence of GPCR energy landscapes Structural and Computational Insights into Dynamics and Intermediate States
- 📰 GPCR Weekly News, March 27 to April 4, 2023
GPCR Binders, Drugs, and more Predicting allosteric sites using fast conformational sampling as guided
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Genetic code expansion to enable site-specific bioorthogonal labeling of functional G protein-coupled
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
The displayed fit, the concentration of D3 receptor binding sites and the Kd values were calculated post Cross-Regulation of Agonist and Guanosine Nucleotide Binding Sites.
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Proceedings of the National Academy of Sciences of the United States of America, 100(19), 10782–10787
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
scavenging “decoys” in order to either limit chemokines spatial availability or to remove them from in vivo sites
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Predicting GPCR properties: AI models can predict various properties of GPCRs, such as ligand binding sites
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
New scaffolds modulating the CBRs in both the orthosteric and allosteric sites have been developed, supported
- Ode to GPCRs
its signaling partner (β-adrenergic receptor bound to the partial inverse agonist carazolol).[67] In spite










